My brother diagnosed Aug 2022 with stage 4 prostate cancer at age 53. PSA was 44 and he had some mets in his bones(Pelvic). After that he had triplet therapy(every 3 month hormone therapy+ Docetaxol+ Nubeqa), but unfortunately his PSA rising right after he finished his chemotherapy.
He had an appointment with his MO and she told him he has not many options. She told him that he should have a blood test ( for DNA) first and depend on the results he may eligible for 2 clinical trial and if the result would not good then he just could have another chemotherapy!!
My brother lives in Vancouver. He never had any PSMA scan. He just did bone scan and CT scan. We are really confused now. If his DNA test would not be good then he is not eligible for any clinical trial??
Thanks in advance
Written by
rasher1
To view profiles and participate in discussions please or .
I am in Victoria, close to Vancouver, and was diagnosed at 55. Sorry to hear that his triplet therapy is not working. BC Cancer is an excellent facility for cancer treatment. Hopefully your brother likes and trusts his MO. There is very good research into prostate cancer happening in Vancouver.Once a man is diagnosed stage 4, a PSMA PET scan is not necessary unless there is a need to find a small met that is causing a specific problem.
I hope the MO is able to find a treatment plan that is effective for your brother. Best of luck to him.
Thanks very much. As I heard there are too many clinical trial available and I read here that maybe someone tried 3-4 trials or more but his MO told him depends on DNA test you may eligible for trials that I mentioned above. She told him otherwise you hav to do chemo and No other choice.
I am sorry to read this. Please check online for different trials. I did that in the UK for my husband. Check the eligibility criteria for exclusions - some do not want a person who has had a chemo etc. Some may be only available for certain mutations. The only trial that was constantly considered for my husband was a phase 1 trial called Crescendo. It was not dependent on DNA but his bloodwork would sometimes have a slightly smaller platelet count than required or lymphocyte count. We spent a lot of long journeys to consider options. In the end I could not understand why the initial blood check could not have been done in our local hospital to avoid driving 6 hours to be told that the bloods were not right this week or that. So do your own homework. The trial criteria are not too difficult to understand. I would still do PSMA scan to see if he has PSMA avid cells. Ideally also do a PET FDG scan alongside. You do not want too much discordance in those if pluvicto is to be really beneficial. Hope this helps. Good luck.
I'm confused why, in cases of metastatic PCa, MOs are now offering up darolutamide (Nubeqa) in lieu of abiraterone (Zytiga), apalutamide (Erleada), or enzalutamide (Xtandi). While all are anti-androgens, these medications are NOT the same and a switch to one of them from Nubeqa would be a simple course. If the MO balks, I would ask for the specific research paper - in mPCa - that says they are equivalent or that the risks of Nubeqa are so much lower that it isn't worth investigating a switch.
IMO, without checking into these 2nd line hormonal drugs, simply offering up a trial is ridiculous. I do agree that there are other effective chemos to try ( cabazitaxel, Xofigo), but l would start with the simpler choices first.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
Everything about Prostate Cancer
Vale My Brother Brian
2nd round of LU177-PSMA Theraphy didn't go as planned. Immunotherapy in Europe for advanced prostate cancer?
Stage four very aggressive prostate cancer 
Advanced prostate cancer-gleason 9 with lupron
